MaxCyte Inc

NASDAQ:MXCT   2:46:09 PM EDT
5.44
-0.17 (-3.03%)
Earnings Announcements

Maxcyte Reports Third Quarter 2022 Financial Results

Published: 11/09/2022 21:17 GMT
MaxCyte Inc (MXCT) - Maxcyte Reports Third Quarter 2022 Financial Results.
Q3 Revenue Rose 5 Percent to $10.6 Million.
Total Revenue of $10.6 Million in Q3 of 2022, an Increase of 5% Over Q3 of 2021.
Qtrly Loss per Share $0.06.
Q3 Earnings per Share View $-0.09, Revenue View $10.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $12.9 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $13.18 Million
Next Quarter EPS Guidance is expected to be -$0.08

More details on our Analysts Page.